Insider Transactions in Q2 2021 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,926
-0.08%
|
$891,606
$181.11 P/Share
|
|
Jun 29
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
4,926
-0.08%
|
$891,606
$181.11 P/Share
|
|
Jun 28
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,225
-0.13%
|
$1,488,725
$181.15 P/Share
|
|
Jun 28
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,225
-0.13%
|
$1,488,725
$181.15 P/Share
|
|
Jun 25
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
10,846
-0.17%
|
$1,952,280
$180.56 P/Share
|
|
Jun 25
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,846
-0.17%
|
$1,952,280
$180.56 P/Share
|
|
Jun 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,837
-0.03%
|
$330,660
$180.79 P/Share
|
|
Jun 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,837
-0.03%
|
$330,660
$180.79 P/Share
|
|
Jun 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,133
-0.19%
|
$2,208,206
$182.31 P/Share
|
|
Jun 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,133
-0.19%
|
$2,208,206
$182.31 P/Share
|
|
Jun 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,345
-0.15%
|
$1,691,445
$181.86 P/Share
|
|
Jun 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
9,345
-0.15%
|
$1,691,445
$181.86 P/Share
|
|
Jun 18
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,261
-0.02%
|
$226,980
$180.43 P/Share
|
|
Jun 18
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,261
-0.02%
|
$226,980
$180.43 P/Share
|
|
Jun 17
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,927
-0.14%
|
$1,615,787
$181.2 P/Share
|
|
Jun 17
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,927
-0.14%
|
$1,615,787
$181.2 P/Share
|
|
Jun 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,413
-0.28%
|
$3,151,753
$181.13 P/Share
|
|
Jun 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,413
-0.28%
|
$3,151,753
$181.13 P/Share
|
|
Jun 15
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,706
-0.25%
|
$2,858,492
$182.0 P/Share
|
|
Jun 15
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,706
-0.25%
|
$2,858,492
$182.0 P/Share
|
|
Jun 14
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
15,000
-9.68%
|
$2,670,000
$178.96 P/Share
|
|
Jun 14
2021
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.82%
|
$375,000
$25.66 P/Share
|
|
Apr 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
20,729
-0.33%
|
$4,000,697
$193.38 P/Share
|
|
Apr 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,729
-0.33%
|
$4,000,697
$193.38 P/Share
|
|
Apr 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
7,805
-0.12%
|
$1,482,950
$190.51 P/Share
|
|
Apr 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,805
-0.12%
|
$1,482,950
$190.51 P/Share
|
|
Apr 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
14,377
-0.23%
|
$2,702,876
$188.64 P/Share
|
|
Apr 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,377
-0.23%
|
$2,702,876
$188.64 P/Share
|
|
Apr 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,687
-0.25%
|
$2,933,469
$187.02 P/Share
|
|
Apr 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,687
-0.25%
|
$2,933,469
$187.02 P/Share
|
|
Apr 20
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,623
-0.28%
|
$3,207,386
$182.44 P/Share
|
|
Apr 20
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,623
-0.28%
|
$3,207,386
$182.44 P/Share
|
|
Apr 19
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,471
-0.13%
|
$1,524,780
$180.9 P/Share
|
|
Apr 19
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,471
-0.13%
|
$1,524,780
$180.9 P/Share
|
|
Apr 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,528
-0.27%
|
$3,155,040
$180.3 P/Share
|
|
Apr 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,528
-0.27%
|
$3,155,040
$180.3 P/Share
|
|
Apr 15
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
31,270
-0.48%
|
$5,816,220
$186.65 P/Share
|
|
Apr 15
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
3,800
-21.52%
|
$703,000
$185.18 P/Share
|
|
Apr 15
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+17.71%
|
$106,400
$28.32 P/Share
|
|
Apr 15
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
31,270
-0.48%
|
$5,816,220
$186.65 P/Share
|
|
Apr 14
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,720
-0.06%
|
$669,600
$180.48 P/Share
|
|
Apr 14
2021
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
3,000
-31.98%
|
$540,000
$180.0 P/Share
|
|
Apr 14
2021
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+24.23%
|
$84,000
$28.32 P/Share
|
|
Apr 14
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,200
-7.97%
|
$216,000
$180.67 P/Share
|
|
Apr 14
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+7.38%
|
$33,600
$28.32 P/Share
|
|
Apr 14
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,720
-0.06%
|
$669,600
$180.48 P/Share
|